Enzalutamide 160mg Glenza Pack

Product Name: Enzalutamide 160mg Glenza Pack

Enzalutamide 160mg Glenza is a potent hormone therapy designed to treat specific types of cancer by inhibiting the effects of androgens (male hormones) in the body. It is particularly used in the management of prostate cancer.

Indication

This medication is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC).

Dosage

The recommended dosage is 160mg taken orally once daily. It should be swallowed whole with water and can be taken with or without food. Always follow your healthcare provider's instructions regarding dosage.

Contraindications

• Pregnancy and Breastfeeding: Not indicated for use in women. It can cause harm to an unborn baby and should not be used during pregnancy.
• Allergy: Contraindicated in patients with known hypersensitivity to Enzalutamide or any of its components.
• Severe Liver Impairment: Not recommended for patients with severe hepatic impairment.

Note: Always consult your healthcare provider before starting any new medication.